Clinical trial
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
NCT03385538 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
- Lead sponsor
- Zealand University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2015
- Completion date
- July 30, 2017
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.